The Summit

23rd - 25th July 2012

NG Pharma Summit 2012

Summit Venue
Barton Creek Resort & Spa, Austin, Texas

The Next Generation Pharmaceutical Summit has grown to become the standard for senior level pharmaceutical executives looking to share ideas with peers, build partnerships with industry thought leaders, and hear from key experts on how to address some of their most pressing challenges in discovery and development, clinical research and beyond.

  • Previous Summits

White Papers

Comparison of the BD™ P800 and BD™ P700 Blood Collection Systems, BD Vacutainer® K2EDTA tube, and other Protease Inhibitors for the Preservation of Ac

Blood from 4 individual subjects was drawn into P700, P800, and K2EDTA BD evacuated blood collection tubes. Immediately after collection, Linco™ DPP-IV inhibitor or aprotinin was added to designated K2EDTA tubes from each subject. The tubes were immediately centrifuged and the plasma pooled from each tube/inhibitor type collected. An equivalent volume of plasma from each tube/inhibitor type (P700, P800, K2EDTA, K2EDTA+Linco™ DPP-IV inhibitor, and K2EDTA+aprotinin) was spiked within 1 hour of collection with 800 pM of Active GLP-1 (7-36 amide). Each set of plasma pools prepared from each subject was maintained at 25±3°C. Plasma aliquots were taken at 0, 2, 4, 6, 12, 24, 48 and 72 hours and stored frozen below -60°C until assayed for Active GLP-1 by ELISA.

View all